Stifel analyst Stephen Willey reiterated a Hold rating and $2.50 price target on IGM Biosciences (NASDAQ: IGMS).The analyst commented, "We’re ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE